Vidipha Central Pharmaceutical JSC (HOSE:VDP)
Vietnam · Delayed Price · Currency is VND 31,950
+450 (1.43%)
At close: Nov 2, 2026
HOSE:VDP Revenue
Vidipha Central Pharmaceutical JSC had revenue of 230.66B VND in the quarter ending September 30, 2026, with 15.99% growth. This brings the company's total for the last twelve months to 1.01T, up 13.75% year-over-year. In the year 2025, Vidipha Central Pharmaceutical JSC had annual revenue of 985.64B with 5.47% growth. That makes Vidipha Central Pharmaceutical JSC the 29,641st largest company in the world by revenue and 358th in Vietnam.
Revenue (ttm)
1.01T
Revenue Growth
+13.75%
P/S Ratio
0.70
Revenue / Employee
2.15B
Employees
469
Market Cap
705.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 985.64B | 51.15B | 5.47% |
| Jan 1, 2025 | 934.49B | -84.83B | -8.32% |
| Dec 31, 2023 | 1.02T | 11.52B | 1.14% |
| Jan 1, 2023 | 1.01T | 800.84B | 386.97% |
| Dec 31, 2008 | 206.95B | 15.51B | 8.10% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Traphaco JSC | 2.77T |
| Domesco Medical Import - Export Joint-Stock | 2.17T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.15T |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Pharmedic Pharmaceutical Medicinal JSC | 565.40B |
| Central Pharmaceutical Joint Stock Company No3 | 524.41B |
| Mediplantex National Pharmaceutical JSC | 434.97B |